Investing.comDoubao · 实盘不做把握 7/10不做原因:风险收益比不佳
北京时间·🕒 发布 21:44:27·⟳ 抓取 21:44:57 +30s·⚡ 决策 10-15 21:45:35 +38s·12.0 天前
Leidos获美海军健康研究中心5600万美元行为健康研究合同
5600万美元合同分摊到66个月(5.5年)，年化约1020万美元，仅占Leidos约172亿美元年营收的约0.06%，即便按总额也仅约0.33%。对一家约170亿美元营收、500亿美元量级市值的国防IT巨头而言，这笔常规成本补偿/研究型合同不构成有意义的盈利或估值催化，缺乏短线edge。
📄 原文Investing.com↗ 原文
Leidos wins $56 million Navy behavioral health research contract
RESTON, Va. - Leidos (NYSE:LDOS) announced today it has been awarded a contract by the Naval Health Research Center to…
不做 Leidos Holdings（LDOS.US）
合同年化收入约1020万美元，仅占172亿美元年营收约0.06%，对超大市值国防IT股无实质盈利或估值催化，风险回报不足，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Leidos中标5600万美元/66个月的海军行为健康研究合同，方向正面但金额相对其172亿美元年营收极小(年化约0.06%)，属常规政府合同，对股价无实质驱动，回避。
🔎 新鲜度:最早出现 2026-10-15 · 扩散 low · price-in 风险 low ↗
关键理由
- 合同确认为官方新闻稿披露的真实中标，但年化收入仅约1020万美元，对172亿美元营收基数而言materiality可忽略。
主要风险
- 若该合同附带后续更大规模追加期权或扩量，实际价值可能高于基础5600万美元，但当前披露未提及。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-10-15 · 影响 invalidates
5600万/66个月年化约1020万美元，占172亿美元年营收约0.06%，不构成催化；未发现可放大其materiality的追加期权披露。
检索:Leidos 合同 5600万 占营收比例 materiality 原文 ↗
先例如何影响了这次决策
方向:无可对照先例，但大型国防IT承包商小额常规合同普遍不产生显著股价反应。
涨幅量级:无高相似对齐样本；以基本面materiality判断，该合同不足以驱动短线重定价。
形态:无足够样本验证见光死模式。
原文全文
展开原文 · 1,744 字
RESTON, Va. - Leidos (NYSE:LDOS) announced today it has been awarded a contract by the Naval Health Research Center to provide behavioral health research and operational assessments for U.S. military personnel.
The contract, valued at $56 million over 66 months, will focus on identifying risks and protective measures affecting the health, performance and readiness of military personnel throughout the deployment cycle, according to a press release statement.
Leidos will conduct data-driven analyses and develop evidence-based strategies aimed at enhancing resilience and reducing adverse outcomes among service members. The company will assist NHRC in translating scientific findings into practical solutions for force readiness and performance optimization.
"This program reinforces the need for mission-critical health research in the military community," said Sarah McNichol, vice president of Behavioral Health & Readiness at Leidos Health. "It is vitally important we work to improve warfighter readiness by studying the various psychological factors that can impact military populations."
The Naval Health Research Center is one of eight laboratories within the Navy Medical Research & Development Enterprise responsible for optimizing operational readiness and health of U.S. armed forces through behavioral health, epidemiology, readiness, and disease surveillance.
Leidos, headquartered in Reston, Virginia, employs approximately 50,000 people globally and reported annual revenues of approximately $17.2 billion for the fiscal year ended January 2, 2026.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Leidos wins $56 million Navy behavioral health research contract
The contract, valued at $56 million over 66 months, will focus on identifying risks and protective measures affecting the health, performance and readiness of military personnel throughout the deployment cycle, according to a press release statement.
Leidos will conduct data-driven analyses and develop evidence-based strategies aimed at enhancing resilience and reducing adverse outcomes among service members. The company will assist NHRC in translating scientific findings into practical solutions for force readiness and performance optimization.
"This program reinforces the need for mission-critical health research in the military community," said Sarah McNichol, vice president of Behavioral Health & Readiness at Leidos Health. "It is vitally important we work to improve warfighter readiness by studying the various psychological factors that can impact military populations."
The Naval Health Research Center is one of eight laboratories within the Navy Medical Research & Development Enterprise responsible for optimizing operational readiness and health of U.S. armed forces through behavioral health, epidemiology, readiness, and disease surveillance.
Leidos, headquartered in Reston, Virginia, employs approximately 50,000 people globally and reported annual revenues of approximately $17.2 billion for the fiscal year ended January 2, 2026.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Leidos wins $56 million Navy behavioral health research contract
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
32bacbc464· 2026-10-15 21:45 · doubao / doubao-seed-evolving-latest-version · 策略包2226518bfdee当前